APA (7th ed.) Citation

CI, F., & GL, C. (1998). Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin. Oncology, 55(2), 116. https://doi.org/10.1159/000011845

Chicago Style (17th ed.) Citation

CI, Falkson, and Cohen GL. "Mitomycin C, Epirubicin and Cisplatin Versus Mitomycin C Alone as Therapy for Carcinoma of Unknown Primary Origin." Oncology 55, no. 2 (1998): 116. https://doi.org/10.1159/000011845.

MLA (9th ed.) Citation

CI, Falkson, and Cohen GL. "Mitomycin C, Epirubicin and Cisplatin Versus Mitomycin C Alone as Therapy for Carcinoma of Unknown Primary Origin." Oncology, vol. 55, no. 2, 1998, p. 116, https://doi.org/10.1159/000011845.